Alivus Life Sciences Limited (NSE: GLS)
India
· Delayed Price · Currency is INR 958.40
-35.50 (-3.57%)
Dec 24, 2024, 3:30 PM IST
Alivus Life Sciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2018 |
| Net Income | 4,235 | 4,709 | 4,670 | 4,187 | 3,516 | 3,131 | Upgrade
|
| Depreciation & Amortization | 535.17 | 497.78 | 406.48 | 369.2 | 322.9 | 284.85 | Upgrade
|
| Other Amortization | 36.74 | 36.74 | 14.46 | 9.57 | 11.04 | 8.83 | Upgrade
|
| Loss (Gain) From Sale of Assets | 21.32 | 10.11 | 5.58 | 7.43 | 5.84 | 12.3 | Upgrade
|
| Stock-Based Compensation | 29.7 | 43.75 | 31.85 | 34.98 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 11.97 | 31.66 | 3.71 | 48.19 | - | - | Upgrade
|
| Other Operating Activities | -112.31 | 147.03 | 64.97 | 320.84 | 1,101 | 415.74 | Upgrade
|
| Change in Accounts Receivable | 308.33 | 378.6 | -1,336 | -592.15 | 81.01 | -1,781 | Upgrade
|
| Change in Inventory | -398.97 | -826.26 | -972.27 | -28.23 | -1,006 | -119.32 | Upgrade
|
| Change in Accounts Payable | -183.29 | -341.21 | 907.79 | 737.49 | 340.89 | 193.02 | Upgrade
|
| Change in Other Net Operating Assets | -314.87 | -551.93 | -735.63 | 881.29 | -491.21 | -195.24 | Upgrade
|
| Operating Cash Flow | 4,169 | 4,135 | 3,060 | 5,976 | 3,881 | 1,950 | Upgrade
|
| Operating Cash Flow Growth | -8.24% | 35.13% | -48.79% | 53.97% | 99.03% | 1783.76% | Upgrade
|
| Capital Expenditures | -1,519 | -1,290 | -1,628 | -1,322 | -679.93 | -511.66 | Upgrade
|
| Sale of Property, Plant & Equipment | 4.65 | 4.65 | 1.74 | 4.69 | 16.34 | 2.93 | Upgrade
|
| Investment in Securities | - | - | 1.11 | 28.05 | -28.05 | - | Upgrade
|
| Other Investing Activities | 170.55 | 120.21 | 157.66 | 66.7 | 4.3 | 3.55 | Upgrade
|
| Investing Cash Flow | -1,344 | -1,165 | -1,467 | -1,222 | -687.34 | -505.18 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -9,329 | -2,138 | -1,366 | Upgrade
|
| Long-Term Debt Repaid | - | -22.09 | -11.28 | -13.65 | - | - | Upgrade
|
| Total Debt Repaid | -23.09 | -22.09 | -11.28 | -9,342 | -2,138 | -1,366 | Upgrade
|
| Net Debt Issued (Repaid) | -23.09 | -22.09 | -11.28 | -9,342 | -2,138 | -1,366 | Upgrade
|
| Issuance of Common Stock | 1 | - | - | 10,119 | - | - | Upgrade
|
| Common Dividends Paid | -2,757 | -2,757 | -3,859 | -1,287 | - | - | Upgrade
|
| Other Financing Activities | -14.47 | -15.46 | -5.47 | -277.64 | - | - | Upgrade
|
| Financing Cash Flow | -2,793 | -2,794 | -3,876 | -787.96 | -2,138 | -1,366 | Upgrade
|
| Net Cash Flow | 31.7 | 175.91 | -2,283 | 3,966 | 1,056 | 79.37 | Upgrade
|
| Free Cash Flow | 2,650 | 2,845 | 1,432 | 4,654 | 3,201 | 1,438 | Upgrade
|
| Free Cash Flow Growth | -17.82% | 98.69% | -69.23% | 45.39% | 122.55% | 13905.94% | Upgrade
|
| Free Cash Flow Margin | 12.02% | 12.46% | 6.63% | 21.92% | 16.98% | 9.36% | Upgrade
|
| Free Cash Flow Per Share | 21.57 | 23.19 | 11.69 | 39.60 | 29.69 | 13.34 | Upgrade
|
| Cash Interest Paid | 14.47 | 15.46 | 5.47 | 277.64 | - | - | Upgrade
|
| Cash Income Tax Paid | 1,685 | 1,630 | 1,536 | 1,382 | 1,086 | 925.36 | Upgrade
|
| Levered Free Cash Flow | 2,006 | 2,108 | 553.75 | 3,756 | 1,715 | 432.5 | Upgrade
|
| Unlevered Free Cash Flow | 2,015 | 2,117 | 557.17 | 3,931 | 2,262 | 641.97 | Upgrade
|
| Change in Net Working Capital | 517.31 | 1,060 | 2,022 | -1,221 | 902.37 | 1,914 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.